FDA Approves Mitapivat for Thalassemia-Related Anemia

(MedPage Today) — The FDA approved mitapivat (Aqvesme) as a disease-modifying treatment for anemia in adults with alpha- or beta-thalassemia, a rare inherited blood disease that affects hemoglobin production.
An oral pyruvate kinase (PK) activator…